Preventing Venous Thromboembolism after elective total hip arthroplasty surgery - are the current guidelines appropriate? Venous thromboembolism prophylaxis in elective total hip arthroplasty surgery.
Osteoarthritis
Risk assessment modelling
Total hip replacement
Venous thromboembolism
Journal
Journal of clinical orthopaedics and trauma
ISSN: 0976-5662
Titre abrégé: J Clin Orthop Trauma
Pays: India
ID NLM: 101559469
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
22
09
2021
revised:
16
01
2022
accepted:
24
01
2022
entrez:
11
2
2022
pubmed:
12
2
2022
medline:
12
2
2022
Statut:
epublish
Résumé
Venous Thromboembolism after elective Total Hip Arthroplasty surgery is a well-recognised complication, resulting in fatal pulmonary embolism, post thrombotic syndrome and recurrent thrombotic episodes. Guidelines developed by clinical organisations attempt to provide evidence-based recommendations to clinicians. This narrative review evaluated the current available literature in relation to the available guidelines, to evaluate whether the current major guidelines reflect the evidence base. All major clinical guidelines were collated through database searching, alongside the relevant clinical studies. The promotion of a multi-modal approach, combining mechanical and chemical prophylaxis, does appear to be well validated, with mechanical prophylaxis offering positive clinical effects with little negative clinical consequence. Within the current guidelines surrounding VTE prevention in the elective-THA patient, there does appear to be a lack of prescription in relation to risk stratification and adopting personalised approaches for specific patient subsets. We suggest moving away from protocolisation of VTE prevention, given the evidence base is not fully developed to allow a 'one-size-fits-all' approach.
Identifiants
pubmed: 35145851
doi: 10.1016/j.jcot.2022.101782
pii: S0976-5662(22)00018-2
pmc: PMC8814685
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
101782Informations de copyright
© 2022 Delhi Orthopedic Association. All rights reserved.
Déclaration de conflit d'intérêts
No conflict of interest to declare.
Références
Clin Orthop Relat Res. 2014 Mar;472(3):903-12
pubmed: 24264881
Clin Appl Thromb Hemost. 2013 Mar-Apr;19(2):116-8
pubmed: 23529476
Chest. 2012 Feb;141(2 Suppl):e278S-e325S
pubmed: 22315265
J Am Acad Orthop Surg. 2011 Dec;19(12):777-8
pubmed: 22134210
Eur J Surg Suppl. 1994;(571):9-22
pubmed: 7519092
Cardiovasc Diagn Ther. 2017 Dec;7(Suppl 3):S276-S284
pubmed: 29399531
Arch Intern Med. 2003 Jun 9;163(11):1362-6
pubmed: 12796074
Clin Appl Thromb Hemost. 2018 Nov;24(8):1315-1321
pubmed: 29716395
J Arthroplasty. 2016 Sep;31(9 Suppl):180-6
pubmed: 27094244
N Engl J Med. 2008 Jun 26;358(26):2765-75
pubmed: 18579811
Res Pract Thromb Haemost. 2020 Mar 09;4(3):366-376
pubmed: 32211571
N Engl J Med. 2018 Feb 22;378(8):699-707
pubmed: 29466159
PLoS One. 2021 Jun 17;16(6):e0250096
pubmed: 34138850
EFORT Open Rev. 2018 Apr 27;3(4):136-148
pubmed: 29780621
Ann Intern Med. 2001 Nov 20;135(10):858-69
pubmed: 11712876
J Bone Joint Surg Am. 1998 Aug;80(8):1158-66
pubmed: 9730125
Acta Orthop. 2019 Aug;90(4):298-305
pubmed: 31060431
J Am Coll Surg. 2011 Jan;212(1):105-12
pubmed: 21093314
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619883946
pubmed: 31840534
Hip Int. 2010 Jan-Mar;20(1):64-74
pubmed: 20383852
J Arthroplasty. 2020 Jan;35(1):259-264
pubmed: 31530463
Sci Rep. 2016 Mar 29;6:23726
pubmed: 27020475
Lancet. 2012 May 12;379(9828):1835-46
pubmed: 22494827
BMC Musculoskelet Disord. 2018 Sep 8;19(1):322
pubmed: 30193575
J Bone Joint Surg Am. 2000 Jul;82-A(7):929-38
pubmed: 10901307